Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift to “time in range” and other metrics of continuous glucose monitoring (CGM ...

Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.

Our editors tested two popular glucose monitors to determine which is the best for improving ​​diet, sleep and exercise habits.

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.

DexCom Inc. (NASDAQ:DXCM) is one of the best medical technology stocks to invest in. On February 12, DexCom Inc. (NASDAQ:DXCM) shared its Q4 2025 earnings and reported $1.26 billion in quarterly ...

Feb 12 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat Wall Street estimates for fourth-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...

Dexcom is continuing to evolve Stelo beyond basic glucose tracking, announcing a new wave of AI-powered features designed to help users better understand how food and daily habits affect their ...

ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 ...

SAN FRANCISCO – Jake Leach, the new CEO of glucose-monitoring company Dexcom, sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss his vision for the company and how AI and ...